Northwest Biotherapeutics annual return on equity
2002
2003
Northwest Biotherapeutics Return on Equity (ROE) Growth & History (NWBO)
Northwest Biotherapeutics's return on equity was −235.26% for fiscal 2003.
View full Northwest Biotherapeutics company overviewNorthwest Biotherapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2003 | 2003-12-31 | −235.26% | −117.84 pp |
| 2002 | 2002-12-31 | −117.42% | — |
Northwest Biotherapeutics return on equity trends
Between the periods ended 2002-12-31 and 2003-12-31, Northwest Biotherapeutics's return on equity decreased from −117.42% to −235.26%, a change of −117.84 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Northwest Biotherapeutics source filings ↗